Year: 2025
Type: article
Abstract: Higher-risk myelofibrosis is a complex disease requiring individualized care. At JADPRO Live 2024, presenters reviewed pathophysiology, diagnosis, risk assessment, and symptom management strategies for myelofibrosis. They also explored treatment options for higher-risk myelofibrosis, balancing benefits and risks while considering patient preferences and goals.
Author: Julie Huynh-Lu, MPAS, PA-C
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4409003633
